Mr. Ibrahem/Oxymetazoline
Clinical data
Trade namesAfrin, Ocuclear, Drixine, others
Other namesOxymetazoline hydrochloride
AHFS/Drugs.comGeneral: Monograph
Topical: Monograph
Pregnancy
category
  • C
Dependence
liability
Moderate
Routes of
administration
Intranasal, eye drops
Drug classAlpha adrenergic agonist[1]
Legal status
Legal status
Pharmacokinetic data
MetabolismKidney (30%), fecal (10%)
Onset of actionWithin 10 min[1]
Elimination half-life5–6 hours
Duration of action6 hrs[1]
Identifiers
  • 3-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
Chemical and physical data
FormulaC16H24N2O
Molar mass260.381 g·mol−1
3D model (JSmol)
Melting point301.5 °C (574.7 °F)
  • Oc1c(c(c(cc1C(C)(C)C)C)CC/2=N/CCN\2)C
  • InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18) checkY
  • Key:WYWIFABBXFUGLM-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Oxymetazoline, sold under many brand name, is a medication used to treat a stuffy nose or eye redness due to minor irritation.[1] It is available as a nasal spray or eye drops.[1] Benefits are seen within 10 minutes and last for up to 6 hours.[1] No more than 3 to 5 days of use is recommended; with use recommended against in those under 6 years.[2][3]

Common side effects may include burning and nasal discharge.[1] Other side effects may include recurrence of stuffiness following stopping use, headache, palpitations, and nervousness.[1] Safety in pregnancy is unclear.[1] It works by activating alpha adrenergic receptor which cases small arteries to narrow.[1]

Oxymetazoline was first made in 1961 and was approved for medical use in the United States in 1986.[2][1] It is available as a generic medication and over the counter.[1] In the United States 30 ml of solution costs about 12 USD as of 2021.[4]

References edit

  1. ^ a b c d e f g h i j k l m n "Oxymetazoline Monograph for Professionals". Drugs.com. Archived from the original on 12 August 2021. Retrieved 10 November 2021.
  2. ^ a b Velpandian, Thirumurthy (29 February 2016). Pharmacology of Ocular Therapeutics. Springer. p. 172. ISBN 978-3-319-25498-2.
  3. ^ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1247. ISBN 978-0857114105.
  4. ^ "Oxymetazoline nasal Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 19 January 2021. Retrieved 10 November 2021.